Does aspirin have a role in preventing unprovoked recurrent thromboembolism?

Article Sidebar

PDF
Published: Apr 14, 2013
DOI: https://doi.org/10.18051/UnivMed.2013.v32.1-2 Universa Medicina
Abstract Viewed: 228
PDF Downloaded: 59
Keywords:
Aspirin role preventing thromboembolism

Main Article Content

Yenny Yenny
Department of Pharmacology, Faculty of Medicine, Trisakti University

Abstract

Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), is a frequently recurring and serious complication after cessation of anticoagulant therapy. Several studies indicate that 10 years after cessation of anticoagulant therapy the risk of recurrent VTE is 39.9% and nearly 50% for unprovoked VTE.

Article Details

How to Cite
Yenny, Y. (2013). Does aspirin have a role in preventing unprovoked recurrent thromboembolism?. Universa Medicina, 32(1), 1–2. https://doi.org/10.18051/UnivMed.2013.v32.1-2
Issue
Vol. 32 No. 1 (2013)
Section
Review Article

The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.

References

Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R. The risk of recurrent venous

thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis

or pulmonary embolism: a prospective cohort study in 1,626 patients. Haematologica 2007;92:199-205.

Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic

therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College

of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e419S-94S.

Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy –

III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical

and medical patients. BMJ 1994;308:235-46.

Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet

therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 2002;324:71-

Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, et al. Aspirin for preventing

the recurrence of venous thromboembolism. N Engl J Med 2012;366:1959-67.

Becattini C, Vedovati MC, Ageno W, Dentali F, Agnelli G. Incidence of arterial cardiovascular events

after venous thromboembolism: a systematic review and a meta-analysis. J Thromb Haemost 2010;8:891-

Brighton TA, Eikelboom J, Mann K, Mister R, Gallus A, Ockelford P, et al. Low dose aspirin for preventing

recurrent venous thromboembolism. N Engl J Med 2012;367:1979-87.